Pantocrin

INSTRUCTION FOR MEDICAL USE OF THE MEDICINAL PRODUCT PANTOCRIN (PANTOCRINUM)

Composition:

Active ingredient: extract from maral antlers, izubr antlers, or spotted deer antlers (1:6.58);

Excipients: "Pear" flavoring, ethanol 52%.

Pharmaceutical form. Liquid alcoholic extract.

Main physico-chemical characteristics: clear light-yellow liquid. Slight sedimentation may occur.

Pharmacotherapeutic group. Tonic agents. ATC code A13A.

Pharmacological properties.

Pharmacodynamics. Natural biologically active substances (amino acids, nucleotides, vitamins, minerals, phospholipids, fatty acids, sterols) contained in the medicinal product are essential for the formation of endogenous enzymes, hormones, cellular and tissue structures, and for strengthening immune defense.

The drug stimulates (tonifies) the nervous system and muscles, metabolism and major physiological processes, promotes adaptation and enhances the body's resistance to adverse environmental factors, increased physical and mental loads, and infectious diseases.

Pharmacokinetics. Not studied.

Clinical characteristics.

Indications.

As part of complex therapy:

• fatigue, nervous exhaustion, neuroses, asthenic conditions caused by infectious diseases (influenza, tuberculosis, etc.), low blood pressure;
• anemia and reduced immunity, respiratory tract diseases, digestive and metabolic disorders (obesity);
• sexual disorders in women (menstrual cycle disturbances, decreased libido) and in men (impotence caused by irradiation, concomitant diseases and psychoemotional stress, premature ejaculation, reduced sexual activity in elderly individuals);
• to enhance work capacity during performance of heavy physical work, and during exposure to harsh climatic and unfavorable ecological conditions.

Contraindications.

Hypersensitivity to the components of the drug, arterial hypertension, organic heart diseases, angina pectoris, pronounced atherosclerosis, increased blood coagulation, severe forms of nephritis, diarrhea, malignant neoplasms.

Interaction with other medicinal products and other types of interactions.

Pantocrin should not be administered concomitantly with calcium-containing preparations, medicinal products that increase blood coagulation (vitamin K), or agents that stimulate contractions of intestinal smooth muscles (domperidone). Pantocrin enhances the effect of piracetam and other nootropic agents.

Special precautions for use.

This medicinal product contains not less than 48% ethanol (alcohol), i.e. 378.8–757.6 mg/dose (20–40 drops), which is equivalent to 9.6–19.2 ml of beer or 4–8 ml of wine.

Harmful for patients suffering from alcoholism. Use with caution in children and in patients with liver disorders or epilepsy.

During prolonged administration of high doses, arterial pressure, blood coagulation, and renal function should be monitored.

If pronounced adverse reactions occur, administration of Pantocrinum should be discontinued and the decision should be made to reduce the dose or discontinue the drug.

Sediment may form during storage; therefore, the product should be shaken before use.

Use during pregnancy or breastfeeding.

The product contains ethanol.

There is no experience with the use of this medicinal product in pregnant or breastfeeding women.

Ability to affect reaction speed when driving or operating machinery.

The product contains ethanol.

The effect of the medicinal product on the ability to drive or operate machinery is unknown.

Dosage and Administration.

For adults: take orally 20–40 drops, previously diluted in a small amount of water, 30 minutes before meals or 2 hours after meals, 2–3 times daily.

For children aged 7 years and older: administer orally at a dosage of 1 drop per year of age, previously diluted in a small amount of water, 30 minutes before meals or 2 hours after meals, twice daily.

The last dose should be taken 4 hours before bedtime.

The treatment course lasts 3–4 weeks. As prescribed by a physician, the course may be repeated.

Children.

The product contains ethanol.

The product is indicated for children aged 7 years and older.

Overdose.

Symptoms of overdose may include headache, skin flushing, nervous excitation, and diarrhea.

Treatment is symptomatic.

Side effects.

Rarely, headache and skin itching may occur during the use of the drug.

Allergic reactions are possible in individuals hypersensitive to the components of the drug.

Shelf life. 3 years.

Storage conditions.

Store in the original packaging at a temperature not exceeding 25 °C.

Keep out of the reach of children.

Packaging.

50 ml in glass or polymer bottles with a dropper cap.

Supply category. Over-the-counter.

Manufacturer/Applicant.

LLC "Ternopharm".

Manufacturer's address / Applicant's address.

46010, Ternopil, Fabrychna St., 4, Ukraine.

Tel./fax: (0352) 521-444, www.ternopharm.com.ua